clinical trial · NCT04488900
Evaluation of the Safety and Tolerability of CKD-508 in Healthy Subjects
Healthy SubjectsCKD-508 CapsulePlacebo CapsuleCKD-508 TabletPlacebo Tablet
brief summary
This study is a first-in-human, randomized, placebo-controlled, 4-part, single ascending dose and multiple ascending dose study. The study is designed to assess the safety, tolerability, PK, and PD and food effect of orally administered CKD-508 capsules and tablets in healthy subjects.
started
Jul 6, 2020
primary completion
Jul 2, 2023
completion
Jul 2, 2023
last updated
Feb 15, 2024
official title
A Phase 1, First-in-Human, Double-blind, Randomized, Placebo Controlled Study to Assess the Safety, Tolerability, PK and PD and Food Effect of CKD-508 After Single and Multiple Ascending Oral Dose Administration in Healthy Adult Subjects
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol